Development of Anti-Infective Drug Products for the Pediatric Population : Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
December 9, 2021
April 11, 2024
93fc101d-c235-4c5e-8254-82649ec6d7fb
Related Documents
Limited Population Pathway for Antibacterial and Antifungal Drugs Guidance for Industry
Guidance DocumentAugust 5, 2020Center for Drug Evaluation and Research
Pediatric HIV Infection: Drug Development for Treatment
Guidance DocumentMarch 20, 2019Center for Drug Evaluation and Research
Rare Diseases: Considerations for the Development of Drugs and Biological Products
Guidance DocumentDecember 26, 2023Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox